Advertisement

Topics

Stand Up To Cancer (SU2C) Company Profile

22:30 EDT 21st October 2018 | BioPortfolio

Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry’s resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease. As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, PhD, conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of the research progress.


News Articles [2058 Associated News Articles listed on BioPortfolio]

SU2C and Lustgarten partner to drive pancreatic cancer research

Not-for-profit organisation Stand Up To Cancer (SU2C) has formed a strategic alliance with US-based Lustgarten Foundation to support research to...Read More... The post SU2C and Lustgarten partner to ...

Stand Up To Cancer Takes New Approach to Multiple Myeloma, Focusing on Precursor Conditions

The SU2C Multiple Myeloma Dream Team will be led by Irene Ghobrial, MD, associate professor of medicine at Dana-Farber Cancer Institute (DFCI) in Boston Read more...

Mayo Clinic physicians receive Stand up to Cancer Catalyst Award for melanoma research

ROCHESTER, Minn. ??Mayo Clinic physicians Matthew Block, M.D., Ph.D. and Tina Hieken, M.D., have received a Stand up to Cancer (SU2C) Catalyst Award to fund melanoma research and a neoadjuvant clinica...

SU2C researchers find promising treatment strategy for stage 1-3 NSCL cancer patients

(Entertainment Industry Foundation) A new, innovative approach to lung cancer treatment, administration of immunotherapy prior to surgery yielded encouraging outcomes in findings from SU2C-CRI Dream T...

With More Than $123.6 Million Pledged So Far In U.S. And Canada In Connection With The Sept. ...

LOS ANGELES, Sept. 9, 2018 /PRNewswire/ -- Stand Up To Cancer (SU2C) today announced more than $123.6 million has been pledged collectively so far in Read more...

We're excited to join @SU2C this Friday, 9/7 to raise funds for #cancer research. Stay tuned! #StandUpToCancer https://twitter.com/SU2C/status/1035951927169896449 …

We're excited to join @SU2C this Friday, 9/7 to raise funds for #cancer research. Stay tuned! #StandUpToCancer https://twitter.com/SU2C/status/1035951927169896449 …

CURE® Inaugural Commercial to Air During SU2C Telecast

Ad to ask people to share how they are more than a patient on social media CURE Media Group, the nation’s leading digital and print media enterprise dedicated to pati...

“Make It a Date” to Start Something Priceless with Mastercard and Stand Up To Cancer

Mindy Kaling Encourages Everyone to Dine Out on 10/10 to Support Cancer Research Mindy Kaling joined Mastercard and Stand Up To Cancer (SU2C) today to encourage people ...

PubMed Articles [6211 Associated PubMed Articles listed on BioPortfolio]

Muscle activity pattern dysfunction during sit to stand and stand to sit in the movement system impairment subgroups of low back pain.

To investigate impairment in the activity pattern of some muscles involved in sit to stand (STD) and stand to sit (STS) among two low back pain (LBP) subgroups of the Movement System Impairment (MSI) ...

Colorectal cancer prevention in Europe - where do we stand?

Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?

To provide an overview of the clinical development of poly(ADP-ribose) polymerase inhibitors (PARPi) in breast cancer to date and to review existing challenges and future research directions.

Sit-Stand Desk Software Can Now Monitor and Prompt Office Workers to Change Health Behaviors.

To determine the effectiveness of a computer-based intervention designed to increase sit-stand desk usage and help reverse workplace physical inactivity.

'Diseases Desperate Grown by Desperate Appliance Are Relieved, or Not at all' - Towards Finding a Cure for Pancreatic Cancer, Where Do We Stand Today?

Clinical Trials [8713 Associated Clinical Trials listed on BioPortfolio]

Sit-to-Stand Training for Survivors of Stroke in a Long-Term Care Setting

The purpose of this study is to see if providing training using a Sit-to-Stand protocol for residents of Long-Term Care Facilities who have had a stroke will increase their independence in...

Stand & Move at Work

A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.

A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting

The purpose of this study is to investigate whether a device that allows office workers to sit or stand whilst working can reduce their sitting time at work and improve their health over 8...

Stand Up and Move More

The purpose of the expanded study is to examine the effectiveness of a "Stand Up and Move More" intervention to reduce sedentary behavior in older adults from underserved communities.

Sit-to-stand Training in Stroke Patient

Background: Manual lifting is a common method to train the sit-to-stand, in which repetition is important. Alternate training regimen by mechanical device may be opted to avoid staff injur...

Companies [1561 Associated Companies listed on BioPortfolio]

Stand Up To Cancer (SU2C)

Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Indust...

Stand Up To Cancer

Stand Up To Cancer (SU2C) -- a program of the Entertainment Industry Foundation (EIF), a 501(c)3 charitable organization -- raises funds to hasten the pace of groundbreaking translational research tha...

SU2C/Amgen

M/s. Kalpdrum Enterprises

M/s. Kalpdrum Enterprises is a growing concern, with leaps and bounds. The only reason that can be attributed to its growth & performance is its strict adherence to quality products and services since...

Cancer for College

Cancer for College was formed in 1993 by two-time cancer survivor and double-amputee Craig Pollard. Cancer for College was created to provide hope and inspiration by providing college scholarships to ...

More Information about "Stand Up To Cancer (SU2C)" on BioPortfolio

We have published hundreds of Stand Up To Cancer (SU2C) news stories on BioPortfolio along with dozens of Stand Up To Cancer (SU2C) Clinical Trials and PubMed Articles about Stand Up To Cancer (SU2C) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stand Up To Cancer (SU2C) Companies in our database. You can also find out about relevant Stand Up To Cancer (SU2C) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record